Your browser is no longer supported. Please, upgrade your browser.
Settings
CSBR [NASD]
Champions Oncology, Inc.
Index- P/E408.46 EPS (ttm)0.03 Insider Own20.68% Shs Outstand14.76M Perf Week2.02%
Market Cap143.16M Forward P/E35.40 EPS next Y0.30 Insider Trans0.00% Shs Float9.97M Perf Month12.74%
Income0.40M PEG27.23 EPS next Q0.00 Inst Own73.10% Short Float0.78% Perf Quarter3.11%
Sales41.00M P/S3.49 EPS this Y114.90% Inst Trans0.26% Short Ratio1.85 Perf Half Y-7.49%
Book/sh0.50 P/B21.24 EPS next Y200.00% ROA1.40% Target Price15.00 Perf Year24.79%
Cash/sh0.35 P/C30.46 EPS next 5Y15.00% ROE5.20% 52W Range7.05 - 14.68 Perf YTD-1.58%
Dividend- P/FCF- EPS past 5Y15.10% ROI3.90% 52W High-28.41% Beta1.21
Dividend %- Quick Ratio1.10 Sales past 5Y29.70% Gross Margin47.70% 52W Low49.08% ATR0.52
Employees194 Current Ratio1.10 Sales Q/Q21.80% Oper. Margin0.80% RSI (14)59.56 Volatility3.24% 4.47%
OptionableYes Debt/Eq0.00 EPS Q/Q81.40% Profit Margin0.90% Rel Volume0.04 Prev Close10.62
ShortableYes LT Debt/Eq0.00 EarningsJul 22 BMO Payout0.00% Avg Volume42.06K Price10.51
Recom2.00 SMA205.71% SMA508.39% SMA200-1.48% Volume414 Change-1.04%
Nov-18-19Initiated The Benchmark Company Speculative Buy
Jul-26-21 08:30AM  
Jul-22-21 08:00AM  
Jul-14-21 08:30AM  
Jul-08-21 03:06AM  
Jun-15-21 09:00AM  
Apr-29-21 03:31AM  
Apr-16-21 12:00PM  
Mar-16-21 10:52AM  
Mar-15-21 02:13AM  
Mar-11-21 04:00PM  
02:30PM  
Mar-05-21 08:30AM  
Mar-04-21 12:30PM  
Feb-22-21 09:00AM  
Jan-29-21 12:24AM  
Jan-19-21 09:00AM  
Jan-05-21 08:30AM  
Dec-15-20 12:22AM  
Dec-14-20 04:00PM  
Dec-07-20 04:00PM  
Nov-16-20 04:40PM  
Nov-11-20 09:00AM  
Oct-31-20 10:08AM  
Sep-16-20 07:27AM  
Sep-14-20 04:00PM  
Sep-08-20 04:30PM  
Jul-30-20 07:21AM  
Jul-27-20 04:01PM  
Jul-22-20 08:00AM  
Jul-15-20 03:55PM  
Jun-17-20 09:37AM  
May-27-20 07:05AM  
Apr-28-20 09:50AM  
Apr-27-20 07:20AM  
Mar-28-20 09:23AM  
Mar-16-20 09:35AM  
Mar-12-20 04:17PM  
Mar-10-20 08:30AM  
Feb-26-20 09:32AM  
Feb-18-20 05:44AM  
Feb-05-20 09:23AM  
Jan-29-20 09:00AM  
Jan-17-20 09:34AM  
Jan-13-20 06:07AM  
Dec-24-19 09:37AM  
Dec-16-19 04:00PM  
Dec-09-19 08:30AM  
Dec-08-19 08:59AM  
Dec-04-19 08:36AM  
Nov-14-19 08:53AM  
Nov-13-19 05:00PM  
Nov-12-19 07:27AM  
Oct-24-19 09:00AM  
Oct-18-19 07:41AM  
Oct-03-19 08:49AM  
Sep-25-19 12:43PM  
Sep-16-19 04:00PM  
02:30PM  
Sep-13-19 08:39AM  
Sep-09-19 08:30AM  
Sep-02-19 01:30PM  
Aug-26-19 08:37AM  
Aug-05-19 08:42AM  
Jul-29-19 06:48PM  
Jul-26-19 06:58AM  
Jul-15-19 04:35PM  
Jul-12-19 10:00AM  
Jul-02-19 09:35AM  
May-31-19 09:37AM  
May-30-19 08:30AM  
May-01-19 08:07AM  
Apr-17-19 09:49AM  
Apr-16-19 10:51AM  
Apr-01-19 08:54AM  
Mar-27-19 10:03AM  
Mar-25-19 10:42AM  
Mar-18-19 04:00PM  
Mar-06-19 08:30AM  
Mar-04-19 11:40PM  
Jan-10-19 08:43AM  
Dec-17-18 03:30PM  
03:00PM  
Dec-10-18 04:30PM  
Nov-22-18 05:45PM  
Nov-16-18 05:45PM  
Nov-15-18 07:20AM  
Nov-07-18 08:30AM  
Nov-05-18 05:45PM  
Nov-02-18 07:27AM  
Oct-29-18 09:30AM  
Oct-23-18 05:45PM  
Oct-12-18 09:30AM  
Oct-04-18 06:55AM  
Oct-01-18 12:10PM  
Sep-28-18 09:15AM  
Sep-21-18 10:00AM  
Sep-20-18 09:15AM  
Sep-13-18 04:05PM  
08:30AM  
Sep-06-18 10:59AM  
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, the company provides POS products, including TumorGraft implants and drug panels, which utilizes TumorGraft technology to test the response of a patient's tumor to multiple oncology drugs or drug combinations. It markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Breitfeld Philip P.DirectorMar 23Option Exercise3.654,16715,2104,167Mar 25 03:27 PM
Poliakoff Abba DavidDirectorJan 19Option Exercise3.4130,000102,30090,147Feb 08 04:46 PM
Breitfeld Philip P.DirectorDec 16Sale11.3531,443356,9760Dec 17 09:29 AM
TOBIN SCOTT RDirectorOct 30Option Exercise5.4610,00054,60010,000Oct 30 04:36 PM
SIDRANSKY DAVIDDirectorOct 16Option Exercise5.4616,66791,002758,334Oct 28 02:53 PM